You may also like
Vasopressor Therapy in Cardiac Surgery—An Experts’ Consensus Statement
The authors unanimously and weakly recommend that clinicians consider early addition of a second vasopressor (norepinephrine or vasopressin) if adequate vascular tone cannot be restored by a monotherapy with either norepinephrine or vasopressin and to consider using vasopressin as a first-line vasopressor or to add vasopressin to norepinephrine in cardiac surgical patients with pulmonary hypertension or right-sided heart dysfunction.
Clinical Experience with Recombinant Tissue Plasminogen Activator in the Management of Intracardiac and Arterial Thrombosis in Children
We aimed to present our experiences with recombinant t-PA (rt-PA) in children with intracardiac or peripheral arterial thrombus. We retrospectively reviewed the children who received rt-PA for thrombus.
Preventing Deep Wound Infection after Coronary Artery Bypass Grafting: A Review
The consequences of deep wound infections before, during, and after coronary artery bypass grafting have prompted research to clarify risk factors and explore preventive measures to keep infection rates at an irreducible minimum.
